Event Brief
Dec 16, 2025 at 3:06 AM ET
Chinese biotech Scizeng’s licensing deal worth $1.44B
By The BriefBrief
Scizeng Medical Technology has signed a $1.44 billion licensing deal with Yarrow Bioscience for GenSci098, an injectable therapy.
WHO: Scizeng Medical Technology, Yarrow Bioscience
WHAT: Global licensing deal for GenSci098 therapy
WHEN: Dec 15, 2025 at 7:00 PM ET
WHERE: Shanghai, China; United States
WHY: To develop and commercialize a therapy for thyroid eye disease and Graves’ disease
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21430 of 21430
Same format. Every time.
Continue reading — sign in or create a free account with
